Amundi
SLS icon

Amundi’s SELLAS Life Sciences SLS Stock Holding History

Amundi’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$170K Buy
+13,791
New +$173K ﹤0.01% 2007

Other funds holding SLS

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
DI
DAGCO Inc Westlake, Ohio $576M AUM 21.79% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Opus Capital Group
Opus Capital Group Cincinnati, Ohio $1.02B AUM 13.75% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return
Everhart Financial Group
Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

Amundi's SLS Position: Q3 2026 in Review

Amundi opened a new position in SELLAS Life Sciences (SLS) in Q3 2026: 13,791 shares worth $170K. The stake represents ﹤0.01% of the portfolio and ranks #2007 among its holdings.

87 funds tracked by Wall St. Rank hold SLS as of Q3 2026.

  • Amundi held 13,791 shares of SELLAS Life Sciences worth $170K as of Q3 2026.
  • SELLAS Life Sciences was a new Amundi position in Q3 2026.
  • SELLAS Life Sciences made up ﹤0.01% of Amundi's portfolio in Q3 2026, its #2007 holding.
  • 87 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q3 2026.

Based on Amundi's 13F filing for Q3 2026, filed 6 Nov 2026.